OTC · BNOEF
Bionomics Limited
$0.01-$0.00 (-14.89%)
Bionomics Limited’s quoted price sits in the lower half of its reported 52-week range, 89.09% below the high.
Loading market information…
OTC · FWPAY · USD
Stock price, earnings
Quote as of Feb 5, 2024, 02:45 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Forward Pharma A/S’s quoted price sits in the lower half of its reported 52-week range, 66.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Forward Pharma A/S’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both inflammatory and neurological conditions. The company was founded in 2005 and its headquarters are located in Copenhagen, Denmark.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| May 12, 2015 |
| -$1.33-0.76% vs estimate |
| $0.00 |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01-$0.00 (-14.89%)
Bionomics Limited’s quoted price sits in the lower half of its reported 52-week range, 89.09% below the high.
$0.50+$0.48 (+2,269.67%)
HealthBeacon plc’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
$0.00-$0.00 (-26.53%)
Tetra Bio-Pharma Inc.: Healthcare · Biotechnology.
$0.09-$0.01 (-7.0%)
Immune Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.85% below the high.
$0.03+$0.03 (0.0%)
Carebook Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.51% below the high.
$1.99+$0.01 (+0.3%)
Polydex Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 1.19% below the high.
$0.06+$0.01 (+32.24%)
Tryp Therapeutics Inc.’s quoted price sits in the upper half of its reported 52-week range, 38.85% below the high.
$0.15$0.00 (0.0%)
Intellipharmaceutics International Inc.: Healthcare · Biotechnology.
